Frequent expression of CD30 in extranodal NK/T ‐cell lymphoma: Potential therapeutic target for anti‐CD30 antibody‐based therapy

In conclusion, frequent expression of CD30 in ENKTL suggests anti‐CD30 antibody‐based therapy may be an effective treatment.

Source: Hematological Oncology - October 20, 2017 Category: Hematology Authors: Keisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki, Yuya Sasaki, Kyohei Yamada, Eriko Yanagida, Reiji Muto, Maiko Kiryu, Hirohito Sone, Masao Seto, Koichi Ohshima, Jun Takizawa Tags: ORIGINAL RESEARCH ARTICLE Source Type: research